Open channel block of HERG K(+) channels by vesnarinone

K Kamiya1, J S Mitcheson, K Yasui

  • 1Department of Circulation, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan. kamiya@riem.nagoya-u.ac.jp

Insights

Vesnarinone, a cardiotonic agent, blocks the human ether-à-go-go-related gene (HERG) channel, preferentially in its open state. This mechanism may explain its unique frequency-dependent action potential duration prolongation.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cardiovascular Physiology

Background:

  • Vesnarinone is a cardiotonic agent known to block I(Kr).
  • Unlike other I(Kr) blockers, it causes frequency-dependent action potential duration (APD) prolongation.
  • The precise mechanism underlying this effect requires elucidation.

Purpose of the Study:

  • To investigate the effects of vesnarinone on the HERG channel, the primary determinant of I(Kr).
  • To identify the specific binding sites of vesnarinone within the HERG channel.
  • To correlate HERG channel block characteristics with vesnarinone's clinical effects.

Main Methods:

  • Heterologous expression of HERG channels in Xenopus laevis oocytes.
  • Electrophysiological recordings to measure HERG currents.
  • Concentration-response analysis and kinetic studies of channel block.
  • Alanine-scanning mutagenesis to identify key residues for vesnarinone binding.

Main Results:

  • Vesnarinone inhibited HERG currents in a concentration-dependent manner (IC(50) = 17.7 microM).
  • Block potency was similar when HERG was coexpressed with MiRP1.
  • Vesnarinone preferentially blocked open HERG channels with minimal effects on rested or inactivated states.
  • Mutagenesis identified six key residues (G648, F656, V659, T623, S624, V625) involved in vesnarinone binding.

Conclusions:

  • Vesnarinone preferentially blocks open HERG channels.
  • The identified binding residues are similar to those for MK-499, suggesting overlapping binding sites.
  • The open-channel block mechanism likely contributes to vesnarinone's favorable frequency-dependent APD prolongation.

Related Concept Videos

Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...